India’s Covaxin gets WHO approval for emergency use listing

This marks a major victory for India’s journey in vaccination against Covid-19

Bharat Biotech’s Covaxin has got WHO approval as the technical advisory team has recommended the India-made vaccine for emergency use listing for 18 years and above, Qazet.az informs referring to Hindustan Times.

This marks a major victory for India’s journey in vaccination against Covid-19.

Covaxin is a vaccine, completely “made in India,” by Hyderabad-based Bharat Biotech and the Indian Council of Medical Research.

The emergency listing got delayed last month as the technical advisory group sought some additional clarification from Bharat Biotech for its final risk assessment.

The technical advisory group met on November 3 to take the final call, and Covaxin has been recommended for emergency use listing.